← Back to screener

AMGEN INC AMGN

Rank #1448 · Nasdaq · $251.5B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
48.0
P/E
37.4
P/B
68.70
ROE
183.5%
Op. Margin
28.0%
Debt Ratio
2409%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E 37.4x, P/B 68.70x. Ranks in the top 70% of the universe.

Profitability ★★★★★
Excellent

ROE 183.5%. Ranks in the top 6% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 2409%. Ranks in the top 98% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★☆☆
Average

Revenue growth of 7.1% year over year. Ranks in the top 43% of the universe.

Profitability is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$14.6B$5.5B$4.6B$20.9B37.6108
2012$15.1B$5.5B$4.6B$22.7B36.8116
2013$15.6B$4.3B$3.7B$23.9B27.7127
2014$17.3B$5.6B$4.3B$19.0B32.3247
2015$18.7B$5.9B$5.1B$19.1B31.4262
2016$20.1B$6.2B$5.2B$22.1B30.9223
2017$21.7B$8.5B$6.9B$25.8B39.1201
2018$23.0B$9.8B$7.7B$28.1B42.6185
2019$22.8B$10.0B$2.0B$29.9B43.6122
2020$23.7B$10.3B$8.4B$25.2B43.2137
2021$23.4B$9.7B$7.8B$12.5B41.4404
2022$25.4B$9.1B$7.3B$9.7B35.9532
2023$26.0B$7.6B$5.9B$9.4B29.4592
2024$26.3B$9.6B$6.6B$6.7B36.31350
2025$28.2B$7.9B$6.7B$3.7B28.02409

← See the full screener